Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Phase I Randomized, Single-blind, Placebo-controlled, Single-center Study of the Effect of Postoperative Administration of Single Dose Ketamine on Pain and Recovery After Robotic Removal of Endometriosis in Patients With Chronic Pelvic Pain

To see complete record on, please visit this link

Id: NCT05229653

Organisation Name: NYU Langone Health

Overal Status: Suspended

Start Date: April 12, 2022

Last Update: January 12, 2023

Lead Sponsor: NYU Langone Health

Brief Summary: This is a randomized, single blinded, placebo-controlled trial to study the effectiveness of a subanesthetic dose (0.6 mg/kg) of ketamine versus placebo (saline) on postoperative pain and pain on adult female chronic pelvic pain patients undergoing robotic removal of endometriosis. The objective of the study is to explore the effect of a sub anesthetic dose of ketamine (0.6 mg/kg) vs. saline control on postoperative pain and recovery in chronic pelvic pain patients who have undergone robotic removal of endometriosis.

  • Endometriosis
  • Post Operative Pain

Total execution time in seconds: 0.62461805343628